UNSPSC 51283201: Filipin

This classification denotes a macrolide antibiotic with the molecular formula C35H58O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 87Z59R7D14 chemically known as oxacyclooctacosa-17,19,21,23,25-pentaen-2-one, 4,6,8,10,12,14,16,27-octahydroxy-3-(1-hydroxyhexyl)-17,28-dimethyl- but generally known as filipin, which bears US NIH Compound Identifier 5351457. European Medicines Agency schedules Filipin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07628MIG.

The term FILIPIN is an International Non-Proprietary Name or INN. Most nations schedule filipin under HS 29419000 and SITC 54139. As of Q4 2014, FILIPIN remains the US FDA Preferred Term for this commodity. SMILES: OC1C(C(O)CCCCC)C(=O)OC(C(O)C=CC=CC=CC=CC=C(C(O)CC(O)CC(O)CC(O)CC(O)CC(O)C1)C)C.

UNSPSC 51283201 Filipin is a Commodity code whose recent state and local procurement activity bears little relevance to the code's nominal scope. The recent opportunities posted under this code—naloxone and drug deactivation systems, direct-to-manufacturer pharmaceutical prescriptions, medical and first aid supplies for fire rescue operations, and generic pharmaceuticals and OTC products—do not align with filipin, a polyene macrolide antibiotic used in clinical settings. The mismatch suggests either a data-entry error in the state and local systems or a tagging convention that does not reflect the actual products being procured. The code shows no recent activity genuinely soliciting filipin or related compounds.

The four posted opportunities span distinct issuing bodies and geographies: Seminole County, Florida (IFB for naloxone and drug deactivation systems, due July 26, 2023); Texas Health and Human Services Commission (RFI for direct-to-manufacturer prescription programs, due April 3, 2026); City of Tampa (IFB for fire rescue medical and first aid supplies, due March 13, 2026, with an estimated contract value of $700,000.00); and Minnesota Multistate Cooperative Purchasing Alliance administered by the Minnesota Department of Administration (RFP for generic pharmaceuticals and OTC products, due March 26, 2026, serving Minnesota and Oregon). None of these solicitations reference filipin or related pharmaceutical agents. Given the absence of genuine market activity under this code, business development professionals should verify the correct UNSPSC classification for their target products before pursuing opportunities tagged with this number.